homocysteine has been researched along with Leukemia, Promyelocytic, Acute in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Assis, PA; Baggio, MS; Bassi, SC; Benício, MT; Falcão, RP; Figueiredo-Pontes, LL; Garcia, AB; Jácomo, RH; Lange, AP; Lima, AS; Oliveira, LO; Rego, EM; Santana-Lemos, BA | 1 |
| Aarbakke, J; Endresen, PC; Lysne, S; Prytz, PS | 1 |
2 other study(ies) available for homocysteine and Leukemia, Promyelocytic, Acute
| Article | Year |
|---|---|
Methionine-induced hyperhomocysteinemia reverts fibrinolytic pathway activation in a murine model of acute promyelocytic leukemia.
Topics: Animals; Annexin A2; Blood Coagulation; Bone Marrow Transplantation; Disease Models, Animal; Fibrinolysin; Fibrinolysis; Homocysteine; Hyperhomocysteinemia; Leukemia, Promyelocytic, Acute; Methionine; Mice; Mice, Inbred C57BL; Mice, Transgenic; Recombinant Proteins; Tissue Plasminogen Activator | 2012 |
Homocysteine increases the relative number of apoptotic cells and reduces the relative number of apoptotic bodies in HL-60 cells treated with 3-deazaadenosine.
Topics: Apoptosis; Cycloheximide; Dactinomycin; DNA; Homocysteine; Humans; Interphase; Leukemia, Promyelocytic, Acute; Tubercidin; Tumor Cells, Cultured | 1994 |